Dongsheng Tu

Dr. Dongsheng Tu is a Professor in the Departments of Public Health Sciences and Mathematics & Statistics at Queen's University, Canada. He serves as a Senior Biostatistician at the Canadian Cancer Trials Group (CCTG) and holds cross-appointments in the Queen's Cancer Research Institute. His primary roles include designing, managing, and analyzing cancer clinical trials, alongside methodological research in statistical procedures for clinical trial design and analysis.

Education:

• Ph.D. in Biostatistics (1994) – Medical University of South Carolina
• B.Sc. in Mathematics (1983) – University of Science and Technology of China

Research Interests:

Dr. Tu's work focuses on statistical methodologies for cancer clinical trials, including longitudinal data analysis, biomarker development, and survival analysis. He collaborates internationally on trials evaluating new drugs and treatments, particularly in colorectal, ovarian, and breast cancers. His methodological contributions include innovative approaches to subgroup identification, missing data handling, and quality-of-life metrics integration.

Grants & Awards:

Not explicitly listed in the text.

Advising & Collaborations:

Dr. Tu oversees numerous clinical trials and collaborates with clinicians globally. He has contributed to pivotal trials such as the CO.17, CO.20, and SOC-1 studies, evaluating treatments like cetuximab and immunotherapies.

Labs/Teams:

He leads the Biostatistics team at the Canadian Cancer Trials Group and is part of the Queen's Cancer Research Institute, fostering interdisciplinary research in oncology and biostatistics.